BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?EBI
University of Clermont Auvergne
Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold.EBI
University of Kansas Specialized Chemistry Center
Ion channels as therapeutic targets: a drug discovery perspective.EBI
Pfizer
Selective TASK-1 Inhibitor with a Defined Structure-Activity Relationship Reduces Cancer Cell Proliferation and Viability.EBI
Centro De Estudios En Alimentos Procesados-Ceap
TASK Channels Pharmacology: New Challenges in Drug Design.EBI
Universidad De Talca
Indoleamine-2,3-dioxygenase inhibitor and preparation method thereforBDB
Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
Pyridine derivatives and their use in the treatment of cancer and hemoglobinopathiesBDB
Ctxt
Amino-triazolopyridine compounds and their use in treating cancerBDB
Astrazeneca
Morpholino compounds, uses and methodsBDB
University of Dundee
Rho kinase inhibitorsBDB
Boehringer Ingelheim International
Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitorsBDB
Bayer Intellectual Property
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.BDB
Virginia Commonwealth University
Characterisation of the specific binding of the histamine H3 receptor antagonist radioligand [3H]GR168320.BDB
Glaxo Research & Development